Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles M Garner

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Journal of the American Chemical Society|June 9, 2018
Correction to "Synthesis and Crystal Structure of an Enantiomerically Pure, Internally Coordinated Alkylchloroborane. The Boron-Centered Anomeric Affect"Christopher S Shiner, Charles M Garner, R Curtis Haltiwanger
Dalton Transactions (Cambridge, England : 2003)|July 13, 2019
A quantitative study of vapor diffusions for crystallizations: rates and solvent parameter changesMichael J Wen, Matthew T Jackson, Charles M Garner
Acta Crystallographica. Section C, Structural Chemistry|June 20, 2024
Preferential crystallization of (±)-pinenyllithium·TMEDAAlexander N Erickson, Curtis Haltiwanger, Masoumeh Rahim, et al.
The Journal of Organic Chemistry|November 19, 2013
Kinetic studies of the epimerization of diastereomeric pyrylium saltsNelson A van der Velde, Holland T Korbitz, Darrin J Bellert, et al.
International Journal of Cancer|July 9, 2004
Combretastatin family member OXI4503 induces tumor vascular collapse through the induction of endothelial apoptosisYezhou Sheng, Jianyi Hua, Kevin G Pinney, et al.
Acta Crystallographica. Section C, Crystal Structure Communications|June 7, 2002
2-(3-tert-Butyldimethylsiloxy-4-methoxyphenyl)-6-methoxy-3-(3,4,5-trimethoxybenzoyl)indoleMallinath B Hadimani, Raymond J Kessler, Jason A Kautz, et al.
Anticancer Research|June 25, 2003
Oxi4503, a novel vascular targeting agent: effects on blood flow and antitumor activity in comparison to combretastatin A-4 phosphateJianyi Hua, Yezhou Sheng, Kevin G Pinney, et al.
Bioorganic & Medicinal Chemistry|January 31, 2006
Design, synthesis, and biological evaluation of combretastatin nitrogen-containing derivatives as inhibitors of tubulin assembly and vascular disrupting agentsKeith A Monk, Rogelio Siles, Mallinath B Hadimani, et al.
Journal of Natural Products|February 29, 2008
Combretastatin dinitrogen-substituted stilbene analogues as tubulin-binding and vascular-disrupting agentsRogelio Siles, J Freeland Ackley, Mallinath B Hadimani, et al.
Journal of Natural Products|September 11, 2013
Synthesis of a 2-aryl-3-aroyl indole salt (OXi8007) resembling combretastatin A-4 with application as a vascular disrupting agentMallinath B Hadimani, Matthew T Macdonough, Anjan Ghatak, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Journal of the American Chemical Society|June 9, 2018
Correction to "Synthesis and Crystal Structure of an Enantiomerically Pure, Internally Coordinated Alkylchloroborane. The Boron-Centered Anomeric Affect"Christopher S Shiner, Charles M Garner, R Curtis Haltiwanger
Dalton Transactions (Cambridge, England : 2003)|July 13, 2019
A quantitative study of vapor diffusions for crystallizations: rates and solvent parameter changesMichael J Wen, Matthew T Jackson, Charles M Garner
Acta Crystallographica. Section C, Structural Chemistry|June 20, 2024
Preferential crystallization of (±)-pinenyllithium·TMEDAAlexander N Erickson, Curtis Haltiwanger, Masoumeh Rahim, et al.
The Journal of Organic Chemistry|November 19, 2013
Kinetic studies of the epimerization of diastereomeric pyrylium saltsNelson A van der Velde, Holland T Korbitz, Darrin J Bellert, et al.
International Journal of Cancer|July 9, 2004
Combretastatin family member OXI4503 induces tumor vascular collapse through the induction of endothelial apoptosisYezhou Sheng, Jianyi Hua, Kevin G Pinney, et al.
Acta Crystallographica. Section C, Crystal Structure Communications|June 7, 2002
2-(3-tert-Butyldimethylsiloxy-4-methoxyphenyl)-6-methoxy-3-(3,4,5-trimethoxybenzoyl)indoleMallinath B Hadimani, Raymond J Kessler, Jason A Kautz, et al.
Anticancer Research|June 25, 2003
Oxi4503, a novel vascular targeting agent: effects on blood flow and antitumor activity in comparison to combretastatin A-4 phosphateJianyi Hua, Yezhou Sheng, Kevin G Pinney, et al.
Bioorganic & Medicinal Chemistry|January 31, 2006
Design, synthesis, and biological evaluation of combretastatin nitrogen-containing derivatives as inhibitors of tubulin assembly and vascular disrupting agentsKeith A Monk, Rogelio Siles, Mallinath B Hadimani, et al.
Journal of Natural Products|February 29, 2008
Combretastatin dinitrogen-substituted stilbene analogues as tubulin-binding and vascular-disrupting agentsRogelio Siles, J Freeland Ackley, Mallinath B Hadimani, et al.
Journal of Natural Products|September 11, 2013
Synthesis of a 2-aryl-3-aroyl indole salt (OXi8007) resembling combretastatin A-4 with application as a vascular disrupting agentMallinath B Hadimani, Matthew T Macdonough, Anjan Ghatak, et al.
Pageof 1